Log In
BCIQ
Print this Print this
 

Natural killer T cells

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Natural killer T cells

BCIQ
Print ChartPrint this
1 - Cancer 1 - Autoimmune 1 - Transplant 1 - Hepatic 1 - Cancer 1 - Inflammation 2 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase II
Autoimmune

-

-

-

1

Cancer

2

1

-

1

Hepatic

-

1

-

-

Inflammation

1

-

-

-

Transplant

-

-

1

-




 Products Targeting Natural killer T cells
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$465.0M

$35.0M

$430.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today